Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 6, 2026

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

Implanted occipital nerve stimulators.

Joseph F Jasper1, Salim M Hayek

  • 1Advanced Pain Medicine Physicians, Tacoma, WA, USA. apmedicine@qwest.net

Pain Physician
|March 21, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High Cervical and Prepontine Intrathecal Drug Delivery for Craniofacial Pain: A Systematic Review.

Neuromodulation : journal of the International Neuromodulation Society·2026
Same author

Not who we treat, but how we treat: Emphasizing treatment adherence in neuromodulation outcomes.

Interventional pain medicine·2026
Same author

Troubleshooting intrathecal pumps in pain management: A clinical review.

Interventional pain medicine·2026
Same author

Intrathecal drug delivery for chronic abdominal pain: A case series.

Interventional pain medicine·2025
Same author

Clinical utility of ECAP dosing in a real-world population delivered via EVOKE therapy: the ECAP study.

Regional anesthesia and pain medicine·2025
Same author

Consensus practice guidelines on sacroiliac joint complex pain from a multispecialty, international working group.

Pain medicine (Malden, Mass.)·2025
Same journal

An Updated (2026) Best-Evidence Synthesis Appraisal of the Diagnostic Accuracy and Utility of Facet (Zygapophysial) Joint Injections in Chronic Spinal Pain.

Pain physician·2026
Same journal

Updated 2026 Comprehensive Evidence-Based Guidelines for Facet Joint Interventions in the Management of Chronic Spinal Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

Pain physician·2026
Same journal

In Errata.

Pain physician·2026
Same journal

In Response to Comment on "BMJ Publications on Interventional Techniques Do Not Meet Appropriateness Criteria of Conducting a Rapid Review: A Comprehensive Review".

Pain physician·2026
Same journal

Comment on "BMJ Publications on Interventional Techniques Do Not Meet Appropriateness Criteria of Conducting a Rapid Review: A Comprehensive Review".

Pain physician·2026
Same journal

In Response to Comment on "Diagnostic Guidance for Chronic Complex Regional Pain Syndrome Type I and Type II from The American Society of Interventional Physicians (ASIPP)".

Pain physician·2026
See all related articles

Occipital nerve stimulation (ONS) offers a promising treatment for chronic headaches, with studies showing significant pain relief and reduced headache frequency. While evidence is limited (Level IV), ONS is considered a valuable tool for severe cases.

Area of Science:

  • Neurology
  • Neurosurgery
  • Pain Management

Background:

  • Chronic headaches pose a significant public health and economic burden.
  • Occipital nerve stimulation (ONS) is a treatment modality involving implanted neurostimulator leads in the occipital region for refractory headaches.
  • ONS has shown potential efficacy across various headache types, including migraine, cluster headaches, and occipital neuralgia.

Purpose of the Study:

  • To systematically review and evaluate the strength of evidence for occipital nerve stimulation (ONS) as an effective treatment for benign headaches.
  • To assess the efficacy of ONS in managing chronic and severe headache conditions.

Main Methods:

  • A systematic literature review was conducted using EMBASE and PubMed/Medline databases.
  • The Agency for Healthcare Research and Quality (AHRQ) criteria were used to assess study quality and evidence strength.

More Related Videos

Minimally Invasive Surgical Decompression of Occipital Nerves
04:06

Minimally Invasive Surgical Decompression of Occipital Nerves

Published on: September 13, 2024

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats
09:39

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats

Published on: July 14, 2020

Related Experiment Videos

Last Updated: Jul 6, 2026

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

Minimally Invasive Surgical Decompression of Occipital Nerves
04:06

Minimally Invasive Surgical Decompression of Occipital Nerves

Published on: September 13, 2024

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats
09:39

Preparation of Peripheral Nerve Stimulation Electrodes for Chronic Implantation in Rats

Published on: July 14, 2020

  • Studies were graded on a 5-level scale, with the overall body of evidence ultimately graded as Level IV (limited).

    • Main Results:

    • Ten observational studies (4 prospective) and various case reports/series were identified; no randomized controlled trials were found.
    • All studies reported positive outcomes, including pain relief, reduced headache frequency/intensity, and decreased medication use.
    • Reported success rates for ONS ranged from 70-100%, with rapid pain reduction in some cases and delayed relief in others. Short-term adverse events included infection and lead displacement.

    Conclusions:

    • Occipital nerve stimulation (ONS) is a valuable therapeutic option for chronic, severe headaches.
    • Despite the limited evidence (Level IV), multiple studies indicate positive patient outcomes with ONS.
    • Further research, including randomized controlled trials, is warranted to solidify the evidence base for ONS efficacy.